|
S100A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.46529496606263E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37719999998765E-06 |
| Normal-vs-Stage2 |
3.377800E-02 |
| Normal-vs-Stage3 |
7.344100E-03 |
| Normal-vs-Stage4 |
2.968500E-02 |
| Stage1-vs-Stage2 |
6.022400E-01 |
| Stage1-vs-Stage3 |
3.873400E-01 |
| Stage1-vs-Stage4 |
3.507000E-01 |
| Stage2-vs-Stage3 |
2.898000E-01 |
| Stage2-vs-Stage4 |
1.864570E-01 |
| Stage3-vs-Stage4 |
7.673800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.31850000204292E-08 |
| Normal-vs-AfricanAmerican |
1.399180E-04 |
| Normal-vs-Asian |
2.575800E-01 |
| Caucasian-vs-AfricanAmerican |
4.646000E-01 |
| Caucasian-vs-Asian |
7.219400E-01 |
| AfricanAmerican-vs-Asian |
9.230200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38650000369722E-08 |
| Normal-vs-Female |
1.424400E-04 |
| Male-vs-Female |
3.875400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.984200E-04 |
| Normal-vs-Extreme_Weight |
3.974900E-04 |
| Normal-vs-Obese |
6.829000E-04 |
| Normal-vs-Extreme_Obese |
9.461000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.871750E-01 |
| Normal_Weight-vs-Obese |
2.528600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.244610E-03 |
| Extreme_Weight-vs-Obese |
8.799600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.757700E-03 |
| Obese-vs-Extreme_Obese |
5.703900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.254630E-01 |
| Normal-vs-Age(41-60Yrs) |
5.80879999999562E-05 |
| Normal-vs-Age(61-80Yrs) |
1.54690000031543E-07 |
| Normal-vs-Age(81-100Yrs) |
1.014850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.672800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.486000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.066000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.944200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.170200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.676000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.597300E-04 |
| Normal-VS-Type2 PRCC |
1.37569999836273E-08 |
| Normal-VS-KIRP CIMP |
4.594000E-01 |
| Normal-VS-Unclassified PRCC |
1.543920E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.798570E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.746000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.263800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.412100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.044370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.070420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.743900E-03 |
| Normal-vs-N1 |
4.460700E-03 |
| Normal-vs-N2 |
3.585000E-01 |
| N0-vs-N1 |
5.769800E-01 |
| N0-vs-N2 |
4.597200E-01 |
| N1-vs-N2 |
6.098000E-01 |
|
|
